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374 The Journal of Thoracic and Cardbjective: The American Joint Committee on Cancer (AJCC) staging system for
sophageal cancer is controversial because it relies on arbitrary definitions of the
natomic location of lymph nodes to establish N and M status. It has been proposed
hat the number of involved lymph nodes may better predict survival. We reviewed
ur experience to determine the prognostic impact of the number of involved nodes
nd the extent of lymphadenectomy on the current staging system.
ethods: Records of all patients who underwent resection of previously untreated
denocarcinoma and squamous cell carcinoma of the esophagus and gastroesoph-
geal junction were reviewed. Overall survival according to the AJCC staging
ystem and the number of involved lymph nodes was analyzed by the method of
aplan and Meier and by recursive partitioning methods.
esults: Data were available on 336 patients operated on between January 1996 and
eptember 2003. Recursive partitioning analysis using AJCC staging variables
eproduced the AJCC staging system. When the number of involved lymph nodes
s added, patients with more than 4 involved lymph nodes have survival similar to
hat of patients with M1 disease, and patients with no involved lymph nodes have
he best prognosis. Recursive partitioning analysis identified 18 lymph nodes as
he minimal number required for accurate staging. In patients who have 18 or
ore lymph nodes removed, survival is only predicted by the presence of nodal
nvolvement and M1 disease.
onclusion: Our analysis suggests that revisions of the current AJCC staging system
or esophageal cancer should include N staging based on the number of involved
ymph nodes and minimal requirements for the extent of lymphadenectomy.
 
he current version of the American Joint Committee on Cancer (A
staging system1 for esophageal cancer has not changed significantly f
previous ones, and it remains controversial. A major concern is that the
urrent descriptors for N staging are based on arbitrary definitions of the anatomic
ocations of lymph nodes, which may not correlate accurately with overall survival.
revious reports from our group and others2-8 suggest that the number of involv
ymph nodes predicts survival more reliably. In addition, the current staging system
oes not fully address the issue of what constitutes an adequate lymphadenectomy
or staging. Both of these features have already been incorporated into the staging
f gastric cancer, which now includes three nodal groupings (N0, N1, and N2) based
n the number of involved lymph nodes, and there is a minimal requirement for the
umber of lymph nodes to be removed below which staging is considered
nreliable.1
The purpose of this study is to analyze our recent experience with a large group
f patients with esophageal cancer treated exclusively by surgical resection, using
iovascular Surgery ● December 2006
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G
TSecursive partitioning methods as a robust statistical ap-
roach to evaluate the issue of lymph node involvement in
sophageal cancer staging. Specifically, we address whether
he number of involved lymph nodes should be part of a
taging system and what constitutes an adequate lymphad-
nectomy for staging purposes. In addition, we investigate
he significance of M1a nodes relative to N1 nodes. Of note,
e do not address in this study separate but important issue
ithin the staging system, namely whether the T1 descriptor
hould be dichotomized into two separate categories as has
een advocated by some.3 Similarly, we do not addre
ther factors that might contribute to a future staging sys-
em, such as tumor differentiation, vascular and neural
nvasion, and extracapsular nodal invasion. Although these
re important considerations, we do not have a sufficient
umber of patients to answer these questions.
ethods
cquisition of Clinical Data
e undertook a retrospective review of all esophagectomies per-
ormed for cancer at Memorial Sloan-Kettering Cancer Center
etween January 1996 and September 2003. January 1996 is the
ime point at which an institutional electronic medical record
ystem was instituted, and it is therefore a date from which highly
eliable data can be obtained. Patients who did not have survival
nformation available were excluded from this analysis. We also
xcluded patients who received induction chemotherapy or radia-
ion before surgery. We included patients who had adenocarci-
oma or squamous cell carcinoma of the thoracic esophagus with
r without involvement of the gastroesophageal junction and gas-
ric cardia.
The data collected included patient demographics, the tumor
istologic type and location, the depth of tumor invasion, and the
umber and location of all malignant and benign lymph nodes.
verall survival, as calculated from the time of operation, was
onfirmed from the Social Security Death Index. January 2004 was
he censoring date for survival.
NM Classification
he T, N, and M descriptors and staging classification used for this
nalysis were those defined in the sixth edition of the AJCC
ancer Staging Manual,1 the version in use at the time this
nalysis was performed. Because of some variations in the nomen-
lature used by surgeons and pathologists in identifying the exact
ocation of lymph nodes within a resected specimen, lymph nodes
ere consistently identified as “celiac axis” if they were labeled as
eft gastric, splenic, celiac, or hepatic. Within the chest, lymph
odes were identified as subcarinal lymph nodes if they were
abeled as level 7, left main stem, or right main stem. M1a nodes
ere labeled according to the primary tumor location. “Celiac
Abbreviations and Acronyms
AJCC American Joint Committee on Cancerxis” nodes were M1a for distal esophageal, gastroesophageal c
The Journal of Thoracicunction, and gastric cardia tumors that involved the gastroesoph-
geal junction. Cervical lymph nodes were M1a for tumors of the
roximal one third of the esophagus. The total number of involved
ymph nodes included any positive lymph node found excluding
emote nodes that would be assigned as M1b. The overall number
f lymph nodes included the sum of all involved lymph nodes plus
ll benign lymph nodes found. Disease was considered M1b if
odes were positive outside the regional basin or if visceral me-
astases were identified. Within the various analyses, we include
wo M categories, namely M1b and M1. M1 combines the M1a
nd M1b descriptors. These two M categories are used in an
ttempt to establish whether M1b and M1a are distinct groups.
ecause M1a nodes and the number of involved lymph nodes are
o closely associated, M1a could not be analyzed in a similar
anner. Therefore, analyses that did not distinguish between M1b
nd M1 nodes were used as indirect evidence of the relevance of
1a nodes. The T stage was based on the depth of tumor invasion
nto the esophageal wall as described in the AJCC staging manual.
tatistical Analysis
atient characteristics are described with categorical variables and
edians and range are used for continuous variables. Survival time
as measured from the date of surgery to the date of death or last
ollow-up. Survival curves were estimated by the Kaplan-Meier
ethod.9 Maximum log-rank analysis10 was used to determine t
ptimal cutoffs for lymph node numbers. Recursive partitionin11
as used to develop a scheme to classify patients into stage
ategories, because the goal of a staging system is to group the
atients into homogenous categories with respect to their progno-
is (in this case overall survival). Because several clinical charac-
eristics (T, N, M, lymph node numbers) affect the prognosis of a
atient, traditional multivariable modeling such as Cox propor-
ional hazards regression to account for these covariates does not
rovide a simple way to group the patients by prognostic catego-
ies. Recursive partitioning, on the other hand, partitions the pa-
ients recursively at each step into two groups on the basis of the
ovariate that gives the maximal separation with respect to their
rognosis. In addition to providing an algorithm to group the
atients into categories, it accounts for interactions between factors
nd, therefore, was considered the most appropriate statistical
ethod for this study. Recursive partitioning was done using the
PART routines of Therneau and Atkinson.12 This algorithm
artitions patients after scaling the survival times so as to fit an
xponential model. The hazard rates in the “exponential-scaled”
imes of terminal nodes are reported. Also reported in the analyses
s the number of patient who died relative to the overall number of
atients within the subset.
esults
linical Data
uring the study period, 710 esophagectomies were per-
ormed, and 336 of these were appropriate for this analysis.
total of 284 patients received chemotherapy and radiation
nd 60 patients received chemotherapy alone before surgery
nd were therefore excluded. Additional patients were ex-
luded because of lack of follow-up (n  10), histologic
lassification other than squamous or adenocarcinoma
and Cardiovascular Surgery ● Volume 132, Number 6 1375
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1
G
TSn  10), inadequate pathologic data (n  5), and prior
sophageal resection (n  5). The median age of the 234
69.6%) men and 102 (30.4%) women was 66.8 years. Patient
emographics, tumor location and histologic type, and the
umbers of involved lymph nodes are shown in Tables 1 
ccording to the 2002 AJCC staging system, 30 patients
ad stage 0 disease, 84 stage I, 67 stage IIa, 31 stage IIb, 70
tage III, 27 stage IVa, and 27 patients had stage IVb
isease.
JCC Staging System
aplan-Meier analysis of overall survival showed poor dis-
rimination between stages IIa and IIb (P  .71), as well as
ABLE 1. Characteristics of the 336 patients studied
haracteristic No. Percent
o. of patients 336
edian age (y) 66.8 (24.6-88.6)
ex (F) 102 30.4
istology
Squamous cell carcinoma 65 19.3
Adenocarcinoma 271 80.7
umor location
Proximal 12 3.6
Middle 30 8.9
Gastroesophageal junction*
Siewert 1 104 31.0
Siewert 2 138 41.1
Siewert 3 52 15.5
JCC stage
0 30 8.9
I 84 25.0
IIa 67 19.9
IIb 31 9.2
III 70 20.8
IVa 27 8.0
IVb 27 8.0
The gastroesophageal junction is partitioned into Siewert 1, 2, and 3
ased on the relative location of the main tumor body to the gastroesoph-
geal junction.28
ABLE 2. Relationship between AJCC stage and number of
ositive lymph nodes
Stage
No. of positive lymph nodes
Median Range
0 0 0
I 0 0
IIa 0 0
IIb 2 1-16
III 4 1-29
IVa 7 1-29
IVb 4 0-18
J
376 The Journal of Thoracic and Cardiovascular Surgery ● Dec2.
etween stages IVa and IVb (P  .81) (Figure 1). Recursiv
artitioning analysis using the variables T, N, and M (M1b
nd M1) essentially recreates the AJCC staging system with
he exception of the M descriptor (Figures 2 and E1)
ost important determinant of overall survival in this anal-
sis is the presence of involved lymph nodes. Among pa-
ients with N0 tumors, T stage had a significant impact on
urvival, with stages T0, T1, and T2-4 forming distinct
urvival curves. Among node-positive patients, T1-2 N1
0, T3-4 N1 M0, and T3-4 N1 M1 form separate survival
urves. This analysis indicates no significant difference
etween the M1 and M1b categories. In summary, recursive
artitioning analysis using the established variables within
he AJCC system supports the current stage groupings ex-
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igure 1. Kaplan-Meier analysis of overall survival showed poor
iscrimination between stages IIa and IIb (P  .71), as well as
etween stages IVa and IVb (P  .81).
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nd M (M1b and M1) essentially recreates the AJCC staging
ystem with the exception of the M descriptor. AJCC, American
oint Committee on Cancer.
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G
TSept for the distinction between IVa and IVb, which should
e combined.
ignificance of the Number of Involved Lymph Nodes
ecursive partitioning analysis that includes the number of
nvolved lymph nodes as a variable in addition to T, N, and
(M1b and M1) identified the presence of more than 4
nvolved lymph nodes as the single most important discrim-
nator of survival, irrespective of T stage (Figures 3 and
his group of patients, which includes 29 of 54 patients
aving either stage IVa or IVb disease according to the
JCC system, has an overall survival (median 14.1 months)
hat is similar to that of the remaining patients who are in
tage IV under the current AJCC system (median 18.5
onths) (P  .24). A more focused analysis of survival in
elationship to the number of involved lymph nodes was
one in T2-3 tumors. This analysis excluded T1 lesions
ecause only 14 of these 98 patients had lymph nodes
nvolved, and including these patients in the analysis would
ave the effect of biasing the survival in favor of node-
egative patients. T4 patients were also excluded because
here were only 2 patients in this group, both of whom were
ode positive. Results from this analysis show that 0 and
ore than 4 positive lymph nodes form distinct prognostic
roups in T2-3 tumors and that in patients with between 3
nd 4 positive lymph nodes the prognosis worsens signifi-
antly (Figure 4). Thus, within AJCC stages IIb, III,
Va, distinct survival curves are generated if patients are
eparated by these 3 nodal groupings (Figure E3). In 
ary, recursive partitioning analysis that includes the num-
er of involved lymph nodes as a variable identifies greater
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igure 3. Recursive partitioning analysis that includes the num-
er of involved lymph nodes as a variable in addition to T, N, and
(M1b and M1) identified the presence of more than 4 involved
ymph nodes as the single most important discriminator of sur-
ival, irrespective of T stage.han 4 positive lymph nodes as equivalent to current AJCC q
The Journal of Thoracic).
-
tage 4. Additional analysis further identifies 3 prognostic
odal groupings in T2-3 tumors, namely 0, 1 to 3-4, and
ore 4 positive nodes. This analysis also does not support
he distinction between M1a and M1b.
mpact of Overall Lymph Node Number on
JCC Staging
recursive partitioning analysis that includes the total
umber of lymph nodes resected as a variable in addition to
, N, and M (M1b and M1) stages and the number of
nvolved lymph nodes reveals again that patients with more
han 4 lymph nodes involved had the worst survival. Fur-
hermore, among of T2-3 tumors with 0 to 4 involved lymph
odes, survival was significantly better if more than 18
ymph nodes were removed (Figures 5 and E4). The 
xtensive lymphadenectomy in the group with more than 18
ymph nodes removed was reflected in the abdominal com-
artment (mean 14.5 vs 7.2 lymph nodes), the thoracic
ompartment (mean 11.3 vs 4.6 lymph nodes), and the
egion spanning the gastroesophageal junction (mean 7.8 vs
.4 lymph nodes). The consequence of requiring a minimal
ymphadenectomy for adequate staging is evident in a re-
ursive partitioning analysis performed only in patients who
ad more than 18 nodes removed, using T, N, and M (M1b
nd M1) and the number of involved lymph nodes as
ariables. In this analysis, the depth of invasion (T stage) is
o longer a significant predictor of survival, with the best
rognostic group being T anyN (0 positive nodes), followed
y T anyN (1-4 positive nodes) M0. Tumors that were
anyN (1-4 positive nodes) M1 or T anyN (4 positive
odes) M0-1 all had similarly poor prognoses (Figur
nd E5). The probable reason for this difference in 
ival based on the extent of lymphadenectomy is inade-
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1
G
TSn an analysis of the likelihood of identifying involved
ymph nodes when tumors are stratified by depth of invasion
Table 3). In T2 tumors, both the likelihood of findin
odes (P  .01) and the mean number of positive nodes
dentified (P  .046) are higher if more than 18 lymph nodes
re removed. Similarly, in T3 tumors, the mean number of
ositive nodes found is greater in patients with an adequate
ymphadenectomy (P  .01), whereas the likelihood of
nding any N1 nodes was the same (P  .8). In summary,
his analysis identifies 18 total lymph nodes as a threshold,
elow which patients’ extent of disease is likely under-
taged. When an adequate lymphadenectomy is done, fur-
hermore, depth of invasion no longer is prognostic of
urvival, likely owing to a more thorough assessment of the
rue likelihood of nodal involvement.
ignificance of Lymph Node Location (N1 vs M1a)
he impact of node location on prognosis is difficult to
scertain from this group of patients because of the strong
ssociation between M1a nodes and a large nodal burden.
ighteen of the 27 patients with M1a nodes (63%) had more
han 4 involved lymph nodes, and of the remainin
atients, 4 had fewer than 18 lymph nodes removed. Within
he group of adequately staged patients, therefore, only 5 of
27 patients (4%) with fewer than 4 involved lymph nodes
ad M1a nodes, further strengthening the association of
1a nodes with a large lymph node burden. Indirectly, each
nalysis that included the M1 and M1b categories pointed to
he lack of distinctness of M1a from M1b nodes.
iscussion
he current AJCC staging system for esophageal cancer
mphasizes the importance of depth of invasion (T) and the
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igure 5. Among of T2-3 tumors with 0 to 4 involved lymph nodes,
urvival was significantly better if more than 18 lymph nodes
ere removed.nvolvement of lymph nodes based on anatomic location c
378 The Journal of Thoracic and Cardiovascular Surgery ● Dec1
N1, M1a). This is different from the current staging sys-
ems for other gastrointestinal tract cancers, including gas-
ric and colorectal cancer, in which N stage is based on the
umber of involved lymph nodes and minimal requirements
or lymphadenectomy exist. For example, in patients with
dequately staged gastric cancer, the number of involved
ymph nodes has been shown to reflect the true burden of
isease and, therefore, to predict outcome.13-15
Similar findings regarding the importance of lymph node
umbers have been reported in esophageal cancer,2-8,15,16
ut with varying recommendations as to the number and
xact cutoffs for lymph node groupings. In our previous
tudy, based on a smaller, more heterogeneous, and earlier
atient cohort, we suggested separating tumors according to
hether they were N0 or had 1 to 3 or 4 or more lymph
odes involved.2 Most studies have also recommended
odal groupings,3-7 while some recommend 415,16 and oth-
rs 2 groupings.8 The basis for selecting these vario
utoffs is not specified in most of these studies, however,
nd often it is not evident how the interactions between the
arious staging variables were accounted for. For instance,
lthough Baba and associates7 propose 3 nodal grouping
N0-1, N2-5, N  5), it is not stated how these numbers
ere chosen, nor were these groupings subjected to a mul-
ivariate analysis. Similarly, while Igaki and associat8
estrict their evaluation to T1 and T2 lesions, they do not
pecify how their lymph node groupings were selected. In
ur current study, we use recursive partitioning analysis as
nonbiased means to identify appropriate lymph node cut-
ffs, with the additional advantage that this type of analysis
ccounts for interactions with other variables. Furthermore,
he recursive partitioning algorithm uses a cross-validation
pproach to prevent the overfitting of data. Thus, we have
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igure 6. In patients with an adequate lymphadenectomy (>18
ymph nodes removed), depth of invasion is no longer a signifi-
ant predictor of survival.onfidence in the reproducibility of the inferences drawn
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G
TSven though the size of the data used is limited. This
esulted in the identification of 3 nodal groups in patients
ith adequately staged disease.
The extent of lymphadenectomy and its impact on stag-
ng, on the other hand, has not been directly addressed in
tudies of the staging of esophageal cancer. There is, how-
ver, indirect evidence of the impact of a lymphadenectomy
n staging. In publications that report more extensive
ymphadenectomies, reported survival is typically better
tage for stage than would be expected.4,17 Although pro-
onents of the more extensive operations attribute this sur-
ival advantage to surgical technique,18,19 this finding could
e at least partially attributed to “stage migration” owing to
etter identification of involved lymph nodes.20 Indeed,
atients who undergo cervical node dissection (3-field) fre-
uently have occult positive lymph nodes detected,17,18,21
ossibly as a result of skip metastases.22 Further evidence
hat a more extensive lymphadenectomy leads to potential
tage migration was shown by Nigro and associate23
herein they demonstrate that in T1 tumors, patients who
ndergo an en bloc esophagectomy are significantly more
ikely to have positive lymph nodes identified than patients
ho have a transhiatal esophagectomy. In our current study,
e show that stage for stage, survival is worse if a lesser
ymphadenectomy is done. Moreover, we show that this
urvival difference is likely to the result of stage migration
ecause the probability of identifying positive lymph nodes
s directly correlated to the adequacy of the lymphadenec-
omy. As a consequence, when only including patients with
n adequate lymphadenectomy, depth of invasion no longer
s prognostic of outcome, and a 3-tiered staging system is
reated based primarily on the number of involved lymph
odes. Because of the close association between the depth
f invasion and the likelihood of lymph node involve-
ent,17,24 it is not surprising that when nodal statu
dequately assessed, depth of invasion would no longer
rovide surrogate information regarding the nodal status
nd T status would no longer independently predict sur-
ival. Supporting evidence for this includes data from Hsu
nd coworkers,25 who found that, once there was no
nvolvement, T status no longer predicted survival. Like-
ise, Altorki and colleagues17 showed that the survival 
ABLE 3. Relationship between depth of invasion and the
he lymphadenectomy
status
Mean no. of positive nodes
<18 nodes >18 nodes P v
T1 0.11 0.52 .
T2 0.79 3.2 .
T3 3.3 5.6 .atients with AJCC stage I is similar to that of patients with p
The Journal of Thoracictage IIa disease, indicating little influence of depth of
nvasion on survival in patients with adequately staged
ode-negative disease. This is in contrast to Orringer, Mar-
hall, and Iannettoni’s experience26 with transhiatal esoph-
gectomy, wherein the 5-year survival of stage I is signifi-
antly better than in stage IIa.
Evaluation of the significance of M1a nodes in this group
f patients showed that there is a strong correlation between
1a status and a large nodal burden. In addition, while a
nivariate comparison of survival between patients with
1a nodes compared with those with N1 nodes does indeed
how the former to have a worse survival (10.6 months vs
0.8 months, P  .006, respectively), in none of our anal-
ses did M1a independently predict survival when analyzed
n conjunction with lymph node number. This result is at
dds with some reports,27 whereas others have supporte
his finding.3,28 Our previous study supported both lym
ode numbers and location as prognostic variables.2 That
tudy, however, included significantly fewer patients (n 
16), 15% of whom received preoperative therapy. Further-
ore, the analysis of lymph node location in our earlier
tudy was done independently of lymph node number, with
he only supporting evidence for the importance of M1a
odes being the lack of correlation between lymph node
umber and lymph node location.
There are several drawbacks in our current study. Al-
hough the median number of nodes removed is relatively
igh compared with most studies, it clearly is also less than
hat some others have reported. In addition, by performing
nly the equivalent of a 2-field lymphadenectomy, we are
ot assessing cervical lymph nodes. These issues might
ontribute to understaging. A separate concern, which we
o not address in this study because of the number of
atients, is the potential difference in staging between squa-
ous cell carcinoma and adenocarcinoma, an issue raised
y Siewert and associates,24 among others. Similarly, th
uestion of whether T1 lesions should be stratified into T1a
nd T1b3 can only be addressed if both depth of inva
nd nodal involvement are addressed. Unfortunately, this
ohort of patients is too small to yield a valid answer, with
nly 26 T1a lesions and 69 T1b lesions, only 13 including
ymph node involvement. Last, a significant number of
lihood of lymph node involvement based on the extent of
N1 disease
<18 nodes >18 nodes P value
3/44 (7%) 8/54 (15%) .2
6/28 (21%) 19/33 (58%) .003
45/63 (71%) 57/82 (70%) .8like
alue
23
05atients with advanced-stage disease were excluded from
and Cardiovascular Surgery ● Volume 132, Number 6 1379
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G
TShis analysis (n  344). At our institution, we at present
ommonly use preoperative chemoradiotherapy in patients
hose clinical stage is IIa or greater, reflecting a change in
ractice compared with the earlier periods in this study. As
uch, the majority of patients in this analysis who have an
dvanced pathologic stage represent patients from earlier
ime points in this series. For instance, in 1996, 82% of the
atients in this analysis were in AJCC stage II or higher,
hereas in 2003 the stage distribution included 65% of
atients with AJCC stages 0 or I. Furthermore, as a group,
he patients in this series were older than patients in our
nstitution who received preoperative therapy (66.8 vs 59.8,
 .001, respectively), reflecting a bias to not offer mul-
imodality treatment in older patients. While excluding pa-
ients who received preoperative therapy is necessary for
roper interpretation of the staging characteristics, the im-
act of the consequent selection bias is unclear.
In summary, the analyses presented in this study suggest
hat several modifications could improve the current esoph-
geal cancer staging system, including a recommendation
hat a minimum of 18 lymph nodes be removed for reliable
taging and that the N stage be separated into 3 categories,
amely N0, 1 to 4 positive nodes, and more than 4 positive
odes. Although not definitive, our results suggest that these
roupings for lymph node involvement could supplant the
1a and M1b descriptors in the current staging system.
hus, a revised staging system could include M0 and M1
escriptors only with M1 designating distant visceral me-
astases, as is common in the AJCC staging systems for
ther malignant diseases. A study with a larger number of
atients would be necessary to incorporate these proposed
ymph node groupings (in the context of an adequate lymph-
denectomy) into a formal staging system. Furthermore, future
tudies with larger numbers of patients will be necessary to
ncorporate additional prognostic variables such as lymph node
ize, evidence of extracapsular nodal invasion, and other his-
ologic and perhaps molecular characteristics of the tumor.
In conclusion, we would recommend that any future
taging system for esophageal cancer include the number of
nvolved lymph nodes rather than just whether lymph nodes
re involved. Furthermore, for the staging system to reliably
epresent the true tumor burden, we would also recommend
hat a minimum number of lymph nodes be removed.29
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TSFigure E1. Recursive partitioning analysis using T, N, M as variables.
Figure E2. Recursive partitioning analysis using T, N, M and number of positive lymph nodes as variables. LN,
Lymph nodes.
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Rizk et al General Thoracic Surgeryigure E3. Recursive partitioning analysis using T, N, M, number
f positive lymph nodes, and total number of lymph nodes as
ariables. LN, Lymph nodes.G
TSigure E4. Recursive partitioning analysis using T, N, M and total
umber of lymph nodes as variables in patients with more than 18
ymph nodes removed. LN, Lymph nodes.
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